ChengDu ShengNuo Biotec Co.,Ltd. (SHA:688117)
China flag China · Delayed Price · Currency is CNY
34.75
-1.29 (-3.58%)
Mar 20, 2026, 3:00 PM CST

ChengDu ShengNuo Biotec Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
741.34451.08431.32386.88369.3
Other Revenue
-4.993.78.8417.23
741.34456.07435.02395.72386.53
Revenue Growth (YoY)
62.55%4.84%9.93%2.38%2.05%
Cost of Revenue
-201.61163.38142.39110.67
Gross Profit
741.34254.46271.64253.33275.86
Selling, General & Admin
-127.76161.01157.82190.73
Research & Development
-49.1729.0523.2913.75
Other Operating Expenses
540.53.111.244.724.8
Operating Expenses
540.5188.4194.37188.29210.14
Operating Income
200.8466.0677.2765.0465.71
Interest Expense
--11.8-9.08-3.24-0.17
Interest & Investment Income
-3.753.924.574.2
Currency Exchange Gain (Loss)
-0.780.53-0.67
Other Non Operating Income (Expenses)
-12.81-0.21-0.29-1.55-0.5
EBT Excluding Unusual Items
188.0358.5772.3367.8268.58
Gain (Loss) on Sale of Investments
-0.16-1.42--
Gain (Loss) on Sale of Assets
--0.59-0.91-0.39-4.89
Other Unusual Items
-3.3710.124.936.8
Pretax Income
188.0361.5180.1272.3670.49
Income Tax Expense
22.2111.679.87.889.24
Earnings From Continuing Operations
165.8249.8470.3264.4861.25
Minority Interest in Earnings
-0.190.01--
Net Income
165.8250.0270.3464.4861.25
Net Income to Common
165.8250.0270.3464.4861.25
Net Income Growth
231.49%-28.88%9.08%5.28%2.09%
Shares Outstanding (Basic)
158156156156141
Shares Outstanding (Diluted)
158159159156141
Shares Change (YoY)
-0.77%0.22%2.03%10.21%20.10%
EPS (Basic)
1.050.320.450.410.43
EPS (Diluted)
1.050.310.440.410.43
EPS Growth
234.08%-29.04%6.90%-4.47%-14.99%
Free Cash Flow
--222.2-193.2-40.23-11.81
Free Cash Flow Per Share
--1.40-1.22-0.26-0.08
Dividend Per Share
-0.1000.1430.1280.153
Dividend Growth
--30.02%11.99%-16.66%-
Gross Margin
100.00%55.79%62.44%64.02%71.37%
Operating Margin
27.09%14.49%17.76%16.44%17.00%
Profit Margin
22.37%10.97%16.17%16.30%15.85%
Free Cash Flow Margin
--48.72%-44.41%-10.17%-3.06%
EBITDA
234.4499.66104.9288.7783.65
EBITDA Margin
31.62%21.85%24.12%22.43%21.64%
D&A For EBITDA
33.5933.5927.6523.7217.94
EBIT
200.8466.0677.2765.0465.71
EBIT Margin
27.09%14.49%17.76%16.44%17.00%
Effective Tax Rate
11.81%18.98%12.23%10.89%13.10%
Revenue as Reported
-456.07435.02395.72386.53
Advertising Expenses
-1.920.50.090.18
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.